ResearchSpace

Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR

Show simple item record

dc.contributor.author Brady, D en_US
dc.contributor.author Steenkamp, Lucia H en_US
dc.contributor.author Skein, E en_US
dc.contributor.author Chaplin, JA en_US
dc.contributor.author Reddy, S en_US
dc.date.accessioned 2007-01-11T11:55:30Z en_US
dc.date.accessioned 2007-06-07T10:04:54Z
dc.date.available 2007-01-11T11:55:30Z en_US
dc.date.available 2007-06-07T10:04:54Z
dc.date.issued 2004-03-04 en_US
dc.identifier.citation Brady, D et al. 2004. Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR. Enzyme and microbial technology, vol 34, 4 March, pp 283-291 en_US
dc.identifier.issn 0141-0229 en_US
dc.identifier.uri http://hdl.handle.net/10204/1381 en_US
dc.identifier.uri http://hdl.handle.net/10204/1381
dc.description.abstract In a biocatalytic reaction the immobilized lipase ChiroCLEC-CR enantioselectively hydrolysed a naproxen ethyl ester racemate, yielding (S)-naproxen with an enantiomeric excess of more than 98%, an enantiomeric ratio (E) of more than 100, and substrate conversion in excess of 40%. Statistically designed experiments were performed to optimise temperature, enzyme to substrate ratio, substrate concentration, agitation, reaction time, pH, buffer concentration and co-solvent addition. Optimisation efforts resulted in more than 20-fold improvement of activity, while the excellent enantioselectivity of the enzymes was maintained. In particular, the addition of PEG 1000 as a co-solvent improved conversion rates 10-fold. The kinetic parameters V-max and K-M were determined to be 0.359_mol/min/mg and 17.6 mM, respectively. The optimised reaction conditions were 10% (m/v) substrate, and enzyme to substrate ratio of 1:50, at 50 degrees C and pH 5 with addition of 41% PEG 1000. In spite of these kinetic improvements, the stability of the biocatalytic activity under these conditions was poor, limiting the number of possible recycles. en_US
dc.format.extent 185111 bytes en_US
dc.format.mimetype application/pdf en_US
dc.language.iso en en_US
dc.publisher Elsevier Science Inc. en_US
dc.rights Copyright: 2004 Elsevier Inc. en_US
dc.subject Candida rugosa lipase en_US
dc.subject Enantioselectivity en_US
dc.subject ChiroCLEC-CR en_US
dc.subject Hydrolysis en_US
dc.subject Naproxen ester en_US
dc.subject S-Naproxen en_US
dc.subject Biotechnology en_US
dc.subject Applied microbiology en_US
dc.title Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR en_US
dc.type Article en_US
dc.identifier.apacitation Brady, D., Steenkamp, L. H., Skein, E., Chaplin, J., & Reddy, S. (2004). Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR. http://hdl.handle.net/10204/1381 en_ZA
dc.identifier.chicagocitation Brady, D, Lucia H Steenkamp, E Skein, JA Chaplin, and S Reddy "Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR." (2004) http://hdl.handle.net/10204/1381 en_ZA
dc.identifier.vancouvercitation Brady D, Steenkamp LH, Skein E, Chaplin J, Reddy S. Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR. 2004; http://hdl.handle.net/10204/1381. en_ZA
dc.identifier.ris TY - Article AU - Brady, D AU - Steenkamp, Lucia H AU - Skein, E AU - Chaplin, JA AU - Reddy, S AB - In a biocatalytic reaction the immobilized lipase ChiroCLEC-CR enantioselectively hydrolysed a naproxen ethyl ester racemate, yielding (S)-naproxen with an enantiomeric excess of more than 98%, an enantiomeric ratio (E) of more than 100, and substrate conversion in excess of 40%. Statistically designed experiments were performed to optimise temperature, enzyme to substrate ratio, substrate concentration, agitation, reaction time, pH, buffer concentration and co-solvent addition. Optimisation efforts resulted in more than 20-fold improvement of activity, while the excellent enantioselectivity of the enzymes was maintained. In particular, the addition of PEG 1000 as a co-solvent improved conversion rates 10-fold. The kinetic parameters V-max and K-M were determined to be 0.359_mol/min/mg and 17.6 mM, respectively. The optimised reaction conditions were 10% (m/v) substrate, and enzyme to substrate ratio of 1:50, at 50 degrees C and pH 5 with addition of 41% PEG 1000. In spite of these kinetic improvements, the stability of the biocatalytic activity under these conditions was poor, limiting the number of possible recycles. DA - 2004-03-04 DB - ResearchSpace DP - CSIR KW - Candida rugosa lipase KW - Enantioselectivity KW - ChiroCLEC-CR KW - Hydrolysis KW - Naproxen ester KW - S-Naproxen KW - Biotechnology KW - Applied microbiology LK - https://researchspace.csir.co.za PY - 2004 SM - 0141-0229 T1 - Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR TI - Optimisation of the enantioselective biocatalytic hydrolysis of naproxen ethyl ester using ChiroCLEC-CR UR - http://hdl.handle.net/10204/1381 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record